This is a demo store. No orders will be fulfilled.

Sibrotuzumab (anti-FAP) - Primary antibody, specific to FAP, Human IgG1, BINDING AGENT of Fibroblast activation protein alpha binding agent, BINDING AGENT of Fibroblast activation protein alpha binding agent

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab183093
Grouped product items
SKU Size
Availability
Price Qty
Ab183093-100μg
100μg
10
$69.90
Ab183093-1mg
1mg
4
$329.90
Ab183093-5mg
5mg
1
$689.90
Ab183093-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,099.90

Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Sibrotuzumab (anti-FAP) - Primary antibody, specific to FAP, Human IgG1, BINDING AGENT of Fibroblast activation protein alpha binding agent
Synonyms 170 kDa melanoma membrane-bound gelatinase antibody | Dipeptidyl peptidase FAP antibody | DPPIV antibody | FAP antibody | FAPA antibody | FAPalpha antibody | Fibroblast activation protein alpha antibody | Gelatine degradation protease FAP antibody | Integ
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity FAP
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type BINDING AGENT
Mechanism of action BINDING AGENT of Fibroblast activation protein alpha binding agent
Product Description

Sibrotuzumab (anti-FAP) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab (anti-FAP) can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC).
Purity
≥95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 148.66 kDa
Purification Method Protein A purified
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 216669-97-5

Associated Targets(Human)

FAP Tchem Prolyl endopeptidase FAP (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Sibrotuzumab (anti-FAP) (Ab183093) - SEC
The purity of Sibrotuzumab (anti-FAP) (Ab183093) is more than 95% verified by HPLC.

Sibrotuzumab (anti-FAP) (Ab183093) - ELISA
Immobilized Human FAP-his tag at 2.0 μg/mL can bind Sibrotuzumab (anti-FAP) (Ab183093) with the EC₅₀ of 2.91 ng/mL.​

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0505671 Certificate of Analysis May 16, 2024 Ab183093
ZJ24F0505670 Certificate of Analysis May 16, 2024 Ab183093
ZJ24F0505669 Certificate of Analysis May 16, 2024 Ab183093

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.